Hemodynamic effects of continuous urodilatin infusion: A dose‐finding study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-09-11

AUTHORS

Guido T. Dorner, Nicole Selenko, Thomas Kral, Leopold Schmetterer, Hans‐Georg Eichler, Michael Wolzt

ABSTRACT

OBJECTIVE: To evaluate the effects of urodilatin (INN, ularitide) on systemic and renal hemodynamic parameters. METHODS: Twenty healthy male subjects were included in this double-blind, randomized placebo-controlled trial and assigned to receive either continuous intravenous infusion of different doses of 7.5, 15, or 22.5 ng/kg body weight/min urodilatin or placebo over 300 minutes. Cardiac performance, systolic time intervals, and airway function were measured noninvasively. The effects on renal hemodynamic values were assessed with para-aminohippurate and inulin clearance techniques. RESULTS: Urodilatin was well tolerated by all subjects at doses of 7.5 and 15 ng/kg/min. Infusion was stopped prematurely for the group that received 22.5 ng/kg/min urodilatin group because of systemic hypotensive responses with nausea and dizziness. Infusion of 15 ng/kg/min urodilatin significantly increased urine flow by a maximum of 165%, filtration fraction by 46%, renal resistance by 49%, and systemic vascular resistance by 45%. It decreased renal plasma flow by a maximum of 31% from baseline value. No change in cardiac inotropic function was detectable, but cardiac output decreased in all dose groups. Effects on glomerular filtration rate, forced expiratory volume, blood pressure, and pulse were not different from those with placebo. CONCLUSION: Continuous infusion of 7.5 ng/kg/min and 15 ng/kg/min urodilatin exerts a significant increase in systemic and renal vascular resistance. Results of our experiments suggested that the therapeutic window for continuous urodilatin infusion is small and that doses higher than approximately 20 ng/kg/min urodilatin carry high risk for adverse drug reactions. More... »

PAGES

322-330

Identifiers

URI

http://scigraph.springernature.com/pub.10.1016/s0009-9236(98)90181-3

DOI

http://dx.doi.org/10.1016/s0009-9236(98)90181-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052818063

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9757156


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrial Natriuretic Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuretics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infusions, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptide Fragments", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renal Circulation", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dorner", 
        "givenName": "Guido T.", 
        "id": "sg:person.01353176734.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353176734.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Selenko", 
        "givenName": "Nicole", 
        "id": "sg:person.01212503046.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212503046.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kral", 
        "givenName": "Thomas", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schmetterer", 
        "givenName": "Leopold", 
        "id": "sg:person.01200335373.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200335373.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eichler", 
        "givenName": "Hans\u2010Georg", 
        "id": "sg:person.014224752232.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014224752232.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria", 
          "id": "http://www.grid.ac/institutes/grid.22937.3d", 
          "name": [
            "Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wolzt", 
        "givenName": "Michael", 
        "id": "sg:person.01071421740.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071421740.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00180284", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010236877", 
          "https://doi.org/10.1007/bf00180284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01726570", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028609592", 
          "https://doi.org/10.1007/bf01726570"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00180055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033442648", 
          "https://doi.org/10.1007/bf00180055"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1992.199", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039035481", 
          "https://doi.org/10.1038/clpt.1992.199"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001010050271", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054510475", 
          "https://doi.org/10.1007/s001010050271"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-09-11", 
    "datePublishedReg": "1998-09-11", 
    "description": "OBJECTIVE: To evaluate the effects of urodilatin (INN, ularitide) on systemic and renal hemodynamic parameters.\nMETHODS: Twenty healthy male subjects were included in this double-blind, randomized placebo-controlled trial and assigned to receive either continuous intravenous infusion of different doses of 7.5, 15, or 22.5 ng/kg body weight/min urodilatin or placebo over 300 minutes. Cardiac performance, systolic time intervals, and airway function were measured noninvasively. The effects on renal hemodynamic values were assessed with para-aminohippurate and inulin clearance techniques.\nRESULTS: Urodilatin was well tolerated by all subjects at doses of 7.5 and 15 ng/kg/min. Infusion was stopped prematurely for the group that received 22.5 ng/kg/min urodilatin group because of systemic hypotensive responses with nausea and dizziness. Infusion of 15 ng/kg/min urodilatin significantly increased urine flow by a maximum of 165%, filtration fraction by 46%, renal resistance by 49%, and systemic vascular resistance by 45%. It decreased renal plasma flow by a maximum of 31% from baseline value. No change in cardiac inotropic function was detectable, but cardiac output decreased in all dose groups. Effects on glomerular filtration rate, forced expiratory volume, blood pressure, and pulse were not different from those with placebo.\nCONCLUSION: Continuous infusion of 7.5 ng/kg/min and 15 ng/kg/min urodilatin exerts a significant increase in systemic and renal vascular resistance. Results of our experiments suggested that the therapeutic window for continuous urodilatin infusion is small and that doses higher than approximately 20 ng/kg/min urodilatin carry high risk for adverse drug reactions.", 
    "genre": "article", 
    "id": "sg:pub.10.1016/s0009-9236(98)90181-3", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "64"
      }
    ], 
    "keywords": [
      "urodilatin infusion", 
      "vascular resistance", 
      "randomized placebo-controlled trial", 
      "effects of urodilatin", 
      "systemic hypotensive responses", 
      "cardiac inotropic function", 
      "placebo-controlled trial", 
      "systemic vascular resistance", 
      "renal vascular resistance", 
      "renal hemodynamic parameters", 
      "glomerular filtration rate", 
      "continuous intravenous infusion", 
      "renal plasma flow", 
      "dose-finding study", 
      "adverse drug reactions", 
      "inulin clearance technique", 
      "healthy male subjects", 
      "systolic time intervals", 
      "hypotensive response", 
      "airway function", 
      "expiratory volume", 
      "hemodynamic effects", 
      "hemodynamic values", 
      "blood pressure", 
      "renal resistance", 
      "inotropic function", 
      "dose group", 
      "intravenous infusion", 
      "cardiac output", 
      "continuous infusion", 
      "filtration rate", 
      "drug reactions", 
      "clearance technique", 
      "urine flow", 
      "hemodynamic parameters", 
      "cardiac performance", 
      "filtration fraction", 
      "baseline values", 
      "therapeutic window", 
      "high risk", 
      "urodilatin", 
      "para-aminohippurate", 
      "male subjects", 
      "infusion", 
      "different doses", 
      "significant increase", 
      "doses", 
      "group", 
      "subjects", 
      "plasma flow", 
      "nausea", 
      "placebo", 
      "dizziness", 
      "min", 
      "trials", 
      "time interval", 
      "effect", 
      "risk", 
      "resistance", 
      "minutes", 
      "response", 
      "interval", 
      "function", 
      "study", 
      "rate", 
      "increase", 
      "volume", 
      "changes", 
      "pressure", 
      "values", 
      "fraction", 
      "results", 
      "flow", 
      "reaction", 
      "technique", 
      "maximum", 
      "window", 
      "output", 
      "parameters", 
      "experiments", 
      "pulses", 
      "performance"
    ], 
    "name": "Hemodynamic effects of continuous urodilatin infusion: A dose\u2010finding study", 
    "pagination": "322-330", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052818063"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1016/s0009-9236(98)90181-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9757156"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1016/s0009-9236(98)90181-3", 
      "https://app.dimensions.ai/details/publication/pub.1052818063"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_283.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1016/s0009-9236(98)90181-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(98)90181-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(98)90181-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(98)90181-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(98)90181-3'


 

This table displays all metadata directly associated to this object as RDF triples.

245 TRIPLES      21 PREDICATES      124 URIs      111 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1016/s0009-9236(98)90181-3 schema:about N040421f18a0542479876f7fd7a25f0f4
2 N07e9519b438d4308b96e3bee6681495a
3 N157691a64d8447258d6a939e443244d0
4 N576ba09e32884cbebb6f149f2a3fc4aa
5 N669b9bd50c094a58bd641a37180d8e50
6 N6c36db22f4ea48f5b886efce052de5de
7 N73ae29d626bb4779bd4af0dd4912ece5
8 N7860b0401279402fb83d42c0aa8f4f56
9 Na08ee6fc0ba3488698da2ea44feff315
10 Nac842a53a43b4727a0011630b6a8beec
11 Nb9bdfa941cfb4b089dde2a50b2ca6463
12 Nf8a37962e77f4b3baa16fbc05d5dbe0c
13 anzsrc-for:11
14 anzsrc-for:1102
15 schema:author Nb5ce56a9fe8d46669e88aa6ababce37a
16 schema:citation sg:pub.10.1007/bf00180055
17 sg:pub.10.1007/bf00180284
18 sg:pub.10.1007/bf01726570
19 sg:pub.10.1007/s001010050271
20 sg:pub.10.1038/clpt.1992.199
21 schema:datePublished 1998-09-11
22 schema:datePublishedReg 1998-09-11
23 schema:description OBJECTIVE: To evaluate the effects of urodilatin (INN, ularitide) on systemic and renal hemodynamic parameters. METHODS: Twenty healthy male subjects were included in this double-blind, randomized placebo-controlled trial and assigned to receive either continuous intravenous infusion of different doses of 7.5, 15, or 22.5 ng/kg body weight/min urodilatin or placebo over 300 minutes. Cardiac performance, systolic time intervals, and airway function were measured noninvasively. The effects on renal hemodynamic values were assessed with para-aminohippurate and inulin clearance techniques. RESULTS: Urodilatin was well tolerated by all subjects at doses of 7.5 and 15 ng/kg/min. Infusion was stopped prematurely for the group that received 22.5 ng/kg/min urodilatin group because of systemic hypotensive responses with nausea and dizziness. Infusion of 15 ng/kg/min urodilatin significantly increased urine flow by a maximum of 165%, filtration fraction by 46%, renal resistance by 49%, and systemic vascular resistance by 45%. It decreased renal plasma flow by a maximum of 31% from baseline value. No change in cardiac inotropic function was detectable, but cardiac output decreased in all dose groups. Effects on glomerular filtration rate, forced expiratory volume, blood pressure, and pulse were not different from those with placebo. CONCLUSION: Continuous infusion of 7.5 ng/kg/min and 15 ng/kg/min urodilatin exerts a significant increase in systemic and renal vascular resistance. Results of our experiments suggested that the therapeutic window for continuous urodilatin infusion is small and that doses higher than approximately 20 ng/kg/min urodilatin carry high risk for adverse drug reactions.
24 schema:genre article
25 schema:isAccessibleForFree false
26 schema:isPartOf N4e93c3b7f4694e578c0699864800f1ef
27 Nb736d18878c945c1ba857e3ff4004619
28 sg:journal.1017409
29 schema:keywords adverse drug reactions
30 airway function
31 baseline values
32 blood pressure
33 cardiac inotropic function
34 cardiac output
35 cardiac performance
36 changes
37 clearance technique
38 continuous infusion
39 continuous intravenous infusion
40 different doses
41 dizziness
42 dose group
43 dose-finding study
44 doses
45 drug reactions
46 effect
47 effects of urodilatin
48 experiments
49 expiratory volume
50 filtration fraction
51 filtration rate
52 flow
53 fraction
54 function
55 glomerular filtration rate
56 group
57 healthy male subjects
58 hemodynamic effects
59 hemodynamic parameters
60 hemodynamic values
61 high risk
62 hypotensive response
63 increase
64 infusion
65 inotropic function
66 interval
67 intravenous infusion
68 inulin clearance technique
69 male subjects
70 maximum
71 min
72 minutes
73 nausea
74 output
75 para-aminohippurate
76 parameters
77 performance
78 placebo
79 placebo-controlled trial
80 plasma flow
81 pressure
82 pulses
83 randomized placebo-controlled trial
84 rate
85 reaction
86 renal hemodynamic parameters
87 renal plasma flow
88 renal resistance
89 renal vascular resistance
90 resistance
91 response
92 results
93 risk
94 significant increase
95 study
96 subjects
97 systemic hypotensive responses
98 systemic vascular resistance
99 systolic time intervals
100 technique
101 therapeutic window
102 time interval
103 trials
104 urine flow
105 urodilatin
106 urodilatin infusion
107 values
108 vascular resistance
109 volume
110 window
111 schema:name Hemodynamic effects of continuous urodilatin infusion: A dose‐finding study
112 schema:pagination 322-330
113 schema:productId N077660cac4354f3fa66a20e838ee6b90
114 N7184739183f848ee803fc4c11807cc22
115 Nbfdddedd170d4a819b0e77d7239d42dd
116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052818063
117 https://doi.org/10.1016/s0009-9236(98)90181-3
118 schema:sdDatePublished 2022-09-02T15:48
119 schema:sdLicense https://scigraph.springernature.com/explorer/license/
120 schema:sdPublisher N34d18e1f438b49408300bbed89ce2876
121 schema:url https://doi.org/10.1016/s0009-9236(98)90181-3
122 sgo:license sg:explorer/license/
123 sgo:sdDataset articles
124 rdf:type schema:ScholarlyArticle
125 N040421f18a0542479876f7fd7a25f0f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Renal Circulation
127 rdf:type schema:DefinedTerm
128 N077660cac4354f3fa66a20e838ee6b90 schema:name pubmed_id
129 schema:value 9757156
130 rdf:type schema:PropertyValue
131 N07e9519b438d4308b96e3bee6681495a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Infusions, Intravenous
133 rdf:type schema:DefinedTerm
134 N157691a64d8447258d6a939e443244d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Hemodynamics
136 rdf:type schema:DefinedTerm
137 N1b3080c8c5e144ffaa25b2cb5cd111ec rdf:first Nbd4eb5e07f294976be857a59a50a26e1
138 rdf:rest N389a653153c44c218a1ee1d86555d46f
139 N34d18e1f438b49408300bbed89ce2876 schema:name Springer Nature - SN SciGraph project
140 rdf:type schema:Organization
141 N35d827d8306c4b1db850806db6b7adff rdf:first sg:person.014224752232.33
142 rdf:rest N877d02fbcbcd45398dbab959395b0eaf
143 N389a653153c44c218a1ee1d86555d46f rdf:first sg:person.01200335373.31
144 rdf:rest N35d827d8306c4b1db850806db6b7adff
145 N4e93c3b7f4694e578c0699864800f1ef schema:issueNumber 3
146 rdf:type schema:PublicationIssue
147 N576ba09e32884cbebb6f149f2a3fc4aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Atrial Natriuretic Factor
149 rdf:type schema:DefinedTerm
150 N5df9503c76bc4e60b18cbf2f7a11ad44 rdf:first sg:person.01212503046.46
151 rdf:rest N1b3080c8c5e144ffaa25b2cb5cd111ec
152 N669b9bd50c094a58bd641a37180d8e50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Male
154 rdf:type schema:DefinedTerm
155 N6c36db22f4ea48f5b886efce052de5de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Adult
157 rdf:type schema:DefinedTerm
158 N7184739183f848ee803fc4c11807cc22 schema:name dimensions_id
159 schema:value pub.1052818063
160 rdf:type schema:PropertyValue
161 N73ae29d626bb4779bd4af0dd4912ece5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Double-Blind Method
163 rdf:type schema:DefinedTerm
164 N7860b0401279402fb83d42c0aa8f4f56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Drug Administration Schedule
166 rdf:type schema:DefinedTerm
167 N877d02fbcbcd45398dbab959395b0eaf rdf:first sg:person.01071421740.29
168 rdf:rest rdf:nil
169 Na08ee6fc0ba3488698da2ea44feff315 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Diuretics
171 rdf:type schema:DefinedTerm
172 Nac842a53a43b4727a0011630b6a8beec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Humans
174 rdf:type schema:DefinedTerm
175 Nb5ce56a9fe8d46669e88aa6ababce37a rdf:first sg:person.01353176734.61
176 rdf:rest N5df9503c76bc4e60b18cbf2f7a11ad44
177 Nb736d18878c945c1ba857e3ff4004619 schema:volumeNumber 64
178 rdf:type schema:PublicationVolume
179 Nb9bdfa941cfb4b089dde2a50b2ca6463 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Peptide Fragments
181 rdf:type schema:DefinedTerm
182 Nbd4eb5e07f294976be857a59a50a26e1 schema:affiliation grid-institutes:grid.22937.3d
183 schema:familyName Kral
184 schema:givenName Thomas
185 rdf:type schema:Person
186 Nbfdddedd170d4a819b0e77d7239d42dd schema:name doi
187 schema:value 10.1016/s0009-9236(98)90181-3
188 rdf:type schema:PropertyValue
189 Nf8a37962e77f4b3baa16fbc05d5dbe0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Dose-Response Relationship, Drug
191 rdf:type schema:DefinedTerm
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
196 schema:name Cardiorespiratory Medicine and Haematology
197 rdf:type schema:DefinedTerm
198 sg:journal.1017409 schema:issn 0009-9236
199 1532-6535
200 schema:name Clinical Pharmacology & Therapeutics
201 schema:publisher Springer Nature
202 rdf:type schema:Periodical
203 sg:person.01071421740.29 schema:affiliation grid-institutes:grid.22937.3d
204 schema:familyName Wolzt
205 schema:givenName Michael
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071421740.29
207 rdf:type schema:Person
208 sg:person.01200335373.31 schema:affiliation grid-institutes:grid.22937.3d
209 schema:familyName Schmetterer
210 schema:givenName Leopold
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200335373.31
212 rdf:type schema:Person
213 sg:person.01212503046.46 schema:affiliation grid-institutes:grid.22937.3d
214 schema:familyName Selenko
215 schema:givenName Nicole
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212503046.46
217 rdf:type schema:Person
218 sg:person.01353176734.61 schema:affiliation grid-institutes:grid.22937.3d
219 schema:familyName Dorner
220 schema:givenName Guido T.
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353176734.61
222 rdf:type schema:Person
223 sg:person.014224752232.33 schema:affiliation grid-institutes:grid.22937.3d
224 schema:familyName Eichler
225 schema:givenName Hans‐Georg
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014224752232.33
227 rdf:type schema:Person
228 sg:pub.10.1007/bf00180055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033442648
229 https://doi.org/10.1007/bf00180055
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/bf00180284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010236877
232 https://doi.org/10.1007/bf00180284
233 rdf:type schema:CreativeWork
234 sg:pub.10.1007/bf01726570 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028609592
235 https://doi.org/10.1007/bf01726570
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/s001010050271 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054510475
238 https://doi.org/10.1007/s001010050271
239 rdf:type schema:CreativeWork
240 sg:pub.10.1038/clpt.1992.199 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039035481
241 https://doi.org/10.1038/clpt.1992.199
242 rdf:type schema:CreativeWork
243 grid-institutes:grid.22937.3d schema:alternateName Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria
244 schema:name Department of Clinical Pharmacology and Institute of Medical Physics Vienna University Vienna Austria
245 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...